Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 12/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 6/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | SHBG | P04278 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | BLM | P54132 | 2/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.56 |
| ▸ | PGR | P06401 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3726244 | 1.00 | HSD17B10 (0.64) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL3768042 | 0.88 | LMNA (0.62) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL5697443 | 0.88 | LMNA (0.51) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL26133329 | 0.88 | LMNA (0.51) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL29018255 | 0.85 | HSD17B10 (0.59) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL3410685 | 0.85 | HIF1A (0.72) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL1182565 | 0.85 | HIF1A (0.72) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL4557526 | 0.84 | SERPINA6 (0.52) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL5982782 | 0.84 | HSD17B10 (0.46) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 | |
| SCHEMBL3640143 | 0.84 | NR3C1 (0.55) | HSD17B10HIF1ASERPINA6CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3350313-A1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | Agency For Science, Technology And Research (A*star) (SG) | 2018-07-25 | — | — | EP | claimed |
| WO-2017048193-A1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2017-03-23 | — | — | WO | claimed |
| EP-1723174-A1 | A NOVEL MODULATOR OF GLUCOCORTICOID RECEPTOR ACTIVITIES | The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health (US) | 2006-11-22 | — | — | EP | claimed |
| WO-2005082935-A1 | STAMP MODULATION OF GLUCOCORTICOID-RESPONSIVE GENE EXPRESSION | GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-09-09 | — | — | WO | claimed |
| EP-3350313-A1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | Agency For Science, Technology And Research (A*star) (SG) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017218815-A1 | MOTOR-ASSOCIATED NEURODEGENERATIVE DISEASE AND METHODS OF TREATMENT | Verge Analytics, Inc. (US) | 2017-12-21 | — | — | WO | disclosed |
| WO-2017048193-A1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2017-03-23 | — | — | WO | disclosed |
| WO-2007041677-A9 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX INC (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007041584-A2 | IMPLANTABLE SENSORS, IMPLANTABLE PUMPS, AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041463-A2 | ELECTRICAL DEVICES AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041677-A2 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| EP-1448205-A4 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX INC (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1723174-A1 | A NOVEL MODULATOR OF GLUCOCORTICOID RECEPTOR ACTIVITIES | The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health (US) | 2006-11-22 | — | — | EP | disclosed |
| WO-2005082935-A1 | STAMP MODULATION OF GLUCOCORTICOID-RESPONSIVE GENE EXPRESSION | GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-09-09 | — | — | WO | disclosed |
| EP-1448205-A2 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | Combinatorx, Incorporated (US) | 2004-08-25 | — | — | EP | disclosed |
| WO-2003030823-A2 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2003-04-17 | — | — | WO | disclosed |